Kathleen Barnes

Kathleen’s career spans >30 years focused on genomic medicine and precision-driven health equity. She completed her BSN at the Medical College of Virginia, her PhD in Biomedical Anthropology at the University of Florida, and a postdoctoral fellowship in Immunogenetics at Johns Hopkins University. She has built research and clinical programs and has led interdisciplinary teams integrating biomedical informatics, multi-omics platforms, translational research and global health at Johns Hopkins University (1993-2015) and the University of Colorado (2015-present), where she founded the Colorado Center for Personalized Medicine,and was SVP of Population Genomics Health at Tempus Labs (2021-2023). Most recently she joined Oxford Nanopore Technologies to stand up a new program in Population Health and Precision Medicine.

Nancy J. Cox

Dr. Nancy Cox is a quantitative human geneticist and the Mary Phillips Edmonds Gray Professor of Genetics at Vanderbilt University Medical Center. Dr. Cox’s research interests focus on large-scale integration of genomics with methods for the analysis of genome data on translational phenotypes and common diseases, such as Alzheimer’s disease. Dr. Cox is a member of the Internal Advisory Committee and an investigator in the Vanderbilt Alzheimer’s Disease Research Center.

Dr. Cox completed her doctoral degree in human genetics at Yale University, a postdoctoral fellowship in psychiatric genetics at Washington University, and a postdoctoral fellowship in the genetics of diabetes at University of Pennsylvania. Dr. Cox joined the Vanderbilt faculty in 2015.

Dr. Kyle Farh

Dr. Kyle Farh is Vice President at Illumina’s Artificial Intelligence (AI) Lab for Genome Interpretation, where he deciphers the clinical impact of genetic variants in rare and common diseases. Towards this goal, Kyle leads a multidisciplinary research team of deep learning scientists, statistical geneticists, and molecular biologists. Prior to joining Illumina, Kyle was an attending physician at Boston Children’s Hospital. Kyle completed his postdoc fellowship in Medical and Population Genetics at the Broad Institute, and received his PhD in Molecular Biology at MIT, MD at Harvard Medical School, and BS in Computer Science from Rice University.

Melissa Haendel

Melissa Haendel is the Director of Precision Health & Translational Informatics and the Sarah Graham Kenan Distinguished Professor in the Department of Genetics at The University of North Carolina at Chapel Hill and co-founder of the Monarch Initiative and the National Covid Cohort Collaborative. Her background is molecular genetics and developmental biology as well as translational informatics, with a focus over the past decade on open science and semantic engineering. Continue reading

Eimear Kenny

Eimear Kenny, PhD, is the Founding Director of the Institute for Genomic Health, building resources for integrating genomic information and AI in routine clinical care, and supporting the sequencing and return of results to a diverse patients in the Mount Sinai Health System. She also the Founding Director of the Center for Translational Genomics and a Professor of Medicine and Genetics, at the Icahn School of Medicine at Mount Sinai, working on computational and translational genomic research.She is Principal Investigator in many large NIH-funded international consortium focused on computational genomics and genomic medicine, including eMERGE, PRIMED, CSER, GSP, TOPMed, PAGE, and HPRC. Continue reading

Josh Peterson

Josh Peterson, MD, MPH serves as a Professor of Biomedical Informatics and Medicine in the School of Medicine at Vanderbilt University Medical Center, the Director of the Center for Precision Medicine, and the Vice-President for Personalized Medicine.

Dr. Peterson is an internationally recognized researcher and educator in Biomedical Informatics and maintains an Internal Medicine practice at VUMC.  He has authored more than 120 peer-reviewed publications, abstracts, reviews, and book chapters.  Dr. Peterson’s research interests are in precision medicine with a focus on clinical decision support to improve drug safety and efficacy, and the translation of genomic technologies to routine clinical care.

Continue reading

Jennifer Posey

As a physician-scientist and a medical and human geneticist, my ultimate goal is to be able to translate our understanding of the relationship between an individual’s genotype and phenotype into actionable and treatable information in the clinic. The first step toward this goal is the elucidation of the complex relationships between genotypes and human disease phenotypes.

Aaron Quinlan

Aaron Quinlan is an Endowed Professor of Human Genetics and Biomedical Informatics at the University of Utah. His laboratory has developed numerous foundational, open-source software tools that facilitate discovery in genomics for thousands of researchers worldwide. His research program explores the causes and consequences of germline and somatic mutations on development, fertility, and health. By applying computational advances to massive genomic datasets, his laboratory has charted maps of genetic constraint in genes, observed surprising variability in the rate at which germline mutations arise and accumulate in sperm, and has unveiled potential connections between germline mutations and health. More information can be found at www.quinlanlab.org.

Angela Brooks

As a splicing specialist, Angela Brooks’s goal is to identify weaknesses in the cancer genome. A Pew Scholar, Brooks is an expert in the analysis of RNA sequencing data and is especially interested in the role of RNA splicing in gene expression. Brooks co-led a research group in the Pan-cancer Analysis of Whole Genomes (Pan-cancer Analysis of Whole Genomes (PCAWG) project, which contributed to the analysis of more than 2,600 genomes of 38 different tumor types, creating a huge resource of primary cancer genomes. Brooks’s Pan-Cancer research focused on changes in gene expression revealed by sequencing the RNA molecules in cancer cells in addition to the DNA sequences that are the focus of most cancer genomics studies. Toward improved detection of RNA molecules in cancer, Brooks’s lab developed the tool FLAIR for transcript detection and quantification from long-read RNA sequencing data. She also co-led the international Long-read RNA-seq Genome Annotation Assessment Project (LRGASP) Consortium to perform a systematic evaluation of long-read RNA sequencing methods.

When The Scientist magazine named her “A Scientist to Watch” in 2017, Brooks emphasized that beyond her lab work, she is also passionate about promoting diversity in research. “I think that’s another big goal I have: To increase the diversity of the data we have, but also to help include scientists from diverse populations to study these genomes.”

Brooks has enhanced diversity and inclusion in STEM at UC Santa Cruz by creating new training opportunities for students from underrepresented groups and leading and mentoring a highly diverse team of graduate and undergraduate student researchers. She is currently PI for the UCSC Genomics Institute’s Research Mentoring Internship Program (RMI), which supports research experiences for undergraduates from groups that are underrepresented in STEM. She has received multiple awards in recognition of her diversity and inclusion efforts including the Chancellor’s Achievement Awards for Diversity and the Outstanding Research and Professional Mentor Award from the Society for Advancement of Chicanos/Hispanics & Native Americans in Science (SACNAS).

Anshul Kundaje

Anshul Kundaje is Associate Professor of Genetics and Computer Science at Stanford University. The Kundaje lab develops statistical and machine learning methods for large-scale integrative analysis of functional genomic data to decode regulatory DNA and networks across diverse cell types and tissues and understand their role in cellular function and disease. Anshul completed his Ph.D. in Computer Science in 2008 from Columbia University. As a postdoc at Stanford University from 2008-2012 and a research scientist at MIT and the Broad Institute from 2012-2014, he led the integrative analysis efforts for two of the largest functional genomics consortia – The Encyclopedia of DNA Elements (ENCODE) and The Roadmap Epigenomics Project. Dr. Kundaje is a recipient of the 2019 Chen Award of Excellence from the Human Genome Organization, 2016 NIH Director’s New Innovator Award and The 2014 Alfred Sloan Foundation Fellowship. Anshul has also served as a member of the NIH Director’s Advisory Committee for Artificial Intelligence in Biomedical Research and the NHGRI Genomic Data Science Working Group.